Group 4D: Triple Negative Breast Cancer; Brain Metastasis; Antibody-Drug Conjugates; Clinical Trials

Poster #TPS1140: Phase I/II study of stereotactic radiation and sacituzumab govitecan with zimberelimab in the management of metastatic triple negative breast cancer with brain metastases

Poster #1097: Comparison of tumor immune microenvironments (TIMEs) between primary and metastatic sites (Mets) in triple-negative breast cancer (TNBC).

Date

Jun 13 2024

Time

10:00 am - 11:30 am

Zoom Webinar

Category
REGISTER